Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR-A Potential Therapeutic Target von Zalcman, Nomi, Gutreiman, Mijal, Shahar, Tal, Weller, Michael, Lavon, Iris

Volltext

Intracranial Assessment of Androgen Receptor Antagonists in Mice Bearing Human Glioblastoma Implants von Zalcman, Nomi, Larush, Liraz, Ovadia, Haim, Charbit, Hanna, Magdassi, Shlomo, Lavon, Iris

Volltext

Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial von Asherie, Nathalie, Kfir-Erenfeld, Shlomit, Avni, Batia, Assayag, Miri, Dubnikov, Tatyana, Zalcman, Nomi, Lebel, Eyal, Zimran, Eran, Shaulov, Adir, Pick, Marjorie, Cohen, Yael, Avivi, Irit, Cohen, Cyrille, Gatt, Moshe E, Grisariu, Sigal, Stepensky, Polina

Volltext

Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR-A Potential Therapeutic Target von Zalcman, Nomi, Gutreiman, Mijal, Shahar, Tal, Weller, Michael, Lavon, Iris

Volltext

Feasibility of a Novel Academic Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis von Lebel, Eyal, Kfir-Erenfeld, Shlomit, Asherie, Nathalie, Grisariu, Sigal, Avni, Batia, Elias, Shlomo, Assayag, Miri, Dubnikov, Tatyana, Zalcman, Nomi, Pick, Marjorie, Zimran, Eran, Cohen, Yael C., Avivi Mazza, Irit, Cohen, Cyrille, Stepensky, Polina, Gatt, Moshe E

Volltext

Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma von Lebel, Eyal, Asherie, Nathalie, Kfir-Erenfeld, Shlomit, Avni, Batia, Grisariu, Sigal, Elias, Shlomo, Assayag, Miri, Dubnikov, Tatyana, Zalcman, Nomi, Pick, Marjorie, Zimran, Eran, Cohen, Yael C., Avivi Mazza, Irit, Cohen, Cyrille, Gatt, Moshe E, Stepensky, Polina

Volltext

Tyrosine Residue in the TRPV1 Vanilloid Binding Pocket Regulates Deactivation Kinetics von Rakesh, Hazan, Adina, Basu, Arijit, Zalcman, Nomi, Matzner, Henry, Priel, Avi

Volltext

Androgen receptor: a potential therapeutic target for glioblastoma von Zalcman, Nomi, Canello, Tamar, Ovadia, Haim, Charbit, Hanna, Zelikovitch, Bracha, Mordechai, Anat, Fellig, Yakov, Rabani, Stav, Shahar, Tal, Lossos, Alexander, Lavon, Iris

Volltext

NIMG-30. PET IMAGING OF ANDROGEN RECEPTOR EXPRESSION IN PATIENTS WITH GBM USING [18F]-FDHT von Mordechai, Anat, Shamni, Ofer, Zalcman, Nomi, Moscovici, Samuel, Chicheportiche, Alexandre, Shoshan, Yigal, Shahar, Tal, Charbit, Hanna, Guterman, Mijal, Paldor, Iddo, Mishani, Eyal, Lossos, Alexander, Orevi, Marina, Lavon, Iris

Volltext

P-026 Safety and efficacy of a locally produced novel anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory multiple myeloma von Lebel, Eyal, Kfir-erenfeld, Shlomit, Asherie, Nathalie, Grisariu, Sigal, Avni, Batia, Elias, Shlomo, Assayag, Miri, Dubnikov, Tatyana, Zalcman, Nomi, Pick, Marjorie, Zimran, Eran, Shaulov, Adir, Cohen, Yaël, Avivi, Irit, Cohen, Cyrille, Stepensky, Polina, Gatt, Moshe

Volltext

OA-34 Feasibility of a novel academic anti-BCMA chimeric antigen receptor T-cell (CART) (HBI0101) for the treatment of relapsed and refractory AL amyloidosis von Lebel, Eyal, Kfir-erenfeld, Shlomit, Asherie, Nathalie, Grisariu, Sigal, Avni, Batia, Elias, Shlomo, Assayag, Miri, Dubnikov, Tatyana, Zalcman, Nomi, Pick, Marjorie, Zimran, Eran, Shaulov, Adir, Cohen, Yaël, Avivi, Irit, Cohen, Cyrille, Stepensky, Polina, Gatt, Moshe

Volltext

[18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma von Orevi, Marina, Shamni, Ofer, Zalcman, Nomi, Chicheportiche, Alexandre, Mordechai, Anat, Moscovici, Samuel, Shoshan, Yigal, Shahar, Tal, Charbit, Hanna, Gutreiman, Mijal, Paldor, Iddo, Mishani, Eyal, Lossos, Alexander, Lavon, Iris

Volltext